Privia Health Group (NASDAQ:PRVA) Stock Price Expected to Rise, Barclays Analyst Says
Privia Health Group (NASDAQ:PRVA – Get Free Report) had its target price upped by equities researchers at Barclays from $23.00 to $25.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s price target suggests a potential upside of 18.32% from [...]